The Chinese Patent Agency has announced the intention to grant a patent regarding Iconovo’s inhalation device, ICOres. Iconovo has previously granted patents in Sweden, Europe (ERPO) and Japan. The new patent covers the technology used in many of Iconovo’s projects like generic Symbicort©.

“China is an enormous market and this patent gives us protection of a very important and fundamental function in ICOres. To have a granted patent in China is crucial when doing business development. This additional patent strengthens our international intellectual property and increases the value of our product portfolio”, says Johan Wäborg, CEO.